Physician profile
Christopher C Webb
NPI 1801879317
$3,098.61
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,147 · 2020: $334 · 2021: $1,489 · 2022: $111 · 2023: $18.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $877.88 | 2019-2021 | |
| Abbvie INC. | $509.12 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $477.53 | 2019-2021 | |
| Astellas Pharma US INC | $156.44 | 2019-2021 | |
| Amgen INC. | $146.83 | 2019 | |
| Esperion Therapeutics, INC. | $136.05 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.37 | 2019 | |
| Neurocrine Biosciences, INC. | $124.08 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $106.46 | 2021 | |
| Supernus Pharmaceuticals, INC. | $81.87 | 2021 | |
| Acadia Pharmaceuticals INC | $80.22 | 2019 | |
| Abbott Laboratories | $60.83 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $51.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.81 | 2021 | |
| Pfizer INC. | $32.22 | 2021-2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $21.17 | 2021 | |
| Allergan, INC. | $16.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.59 | 2021 | |
| Glaxosmithkline, LLC. | $13.82 | 2020 | |
| Nestle Healthcare Nutrition INC. | $13.18 | 2021 | |
| Lilly USA, LLC | $11.46 | 2021 | |
| Dynavax Technologies Corporation | $3.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.